Denver – (Business Wire) – July 9, 2025 –
Cleerly, a leader in advanced cardiovascular imaging, will present new research at the 2025 Annual Meeting of the Association for Computed Cardiovascular Tomography (SCCT). The meeting will be held from July 17-20, 2025 at Palais des Kong de Montreal, Montreal, Canada. This annual event brings together leading cardiovascular imaging specialists, researchers and innovators from around the world to share the latest advances in cardiovascular computed tomography.
This press release features multimedia. Check out the full release here: https://www.businesswire.com/news/home/20250709765120/en/
Cleerly, a leader in advanced cardiovascular imaging, will present new research at the Society of Cardiovascular Computed Tomography (SCCT) Annual Meeting.
Cleerly shares the findings of three scientific summaries. How AI-QCT affects physician prescribing practices, pooled analysis comparing AI-QCT ischemia accuracy with alternative measurements, and pooled analysis, vascular comparison of AI-QCT ischemia and alternative measurements. Check out Cleerly’s complete meeting program schedule below.
Thursday, July 17th: AI/ML Interactive Workshop (8am to 4:30pm). An interactive small group workshop featuring insights from imaging, AI and data science leaders, including Cleerly’s Udo Hoffmann, MD, James K. Min, MD, MD, FACC, FESC and MSCCT. It is designed for medical professionals at every career stage of cardiovascular imaging. Please check what’s important. Gain hands-on experience with Cleerly Labs through live case reviews, guided software use, and clinical challenges. Topics include plaque analysis, ischemia, comparison, CT-induced PCI, and more. Speakers include UDO Hoffmann, MD, Sarah Bär, MD, PhD, Maros Ferencik, MD, PhD, MCR, MSCCT. John Osborne, MD, PhD, FACC, FNLA, Yader Sandoval, MD, FACC, FSCAI, FESC, and Amro Alsaid, MD, FACC, Fase, FSCMR. Todd C. Villines, MD, FSCCT moderates. Registration is open and includes a free dinner. Friday, July 18: Diagnostic performance of AI-QCT ischemia compared to FFR-CT: Patient and vascular level ischemia poster session 2 (9:30am to 10:15am) and Tyler Coomb, MD.MD. will use diagnostic accuracy of latent homogeneity accuracy of latent disorders of latent disorders of atoelosclerosis. Pool Analysis Poster Session 2 (9:30am to 10:15am), Hyung-Bok Park, MD, PhD. Novel Technologies Session (5:5pm to 6:15pm), James K. Min, FACC, FESC, MSCCT, Founder, CEO, “In the future, we will inform you of the future of CT. This opposite session explores the future of cardiovascular CT technology and precision imaging. Saturday, July 19: The impact of atherosclerosis – Quantified computed tomography vs. real-world prescribing session for treatment recommendations (10:40am to 11:30am AM) Compare recommendations with the real-world prescription patterns.compare lunch symposium (12:45pm to 1:45pm). A case-based session to confirm that Cleerly’s advanced plaque imaging exceeds traditional metrics. Learn why LDL alone misses the risk, explores disease tracking with comparisons, and tackles real-world cases with interactive “What do you do?” A scenario like when the calcium score is zero. Speakers include MAMS MIN, MD, FACC, FESC, MSCCT, John Osborne, MD, PhD, FACC, FNLA, MARC BONACA, MD, MPH. Ricardo Curie, MD, FSCCT, and Maros Ferensik, MD, PhD, MCR, MSCCT will ease sessions.
Stop by and find out more about Claire at booth #505. Check out this link to see the full schedule of Cleerly presentations or to schedule a meeting with Cleerly leadership.
About Creeley
Cleerly is a company with a mission to eliminate heart attacks by creating new standard care for heart disease. Through an FDA-clear solution driven by artificial intelligence, Cleerly supports comprehensive phenotypic arrangement of coronary artery disease as determined from progressive, non-invasive CT imaging. Cleerly’s approach is based on science, based on millions of images from over 40,000 patients. Leading by a world-class clinical and technical team, Cleerly strengthens health literacy for all stakeholders in the coronary care pathway. For more information, please visit cleerlyhealth.com.
businesswire.com: View source version at https://www.businesswire.com/news/home/20250709765120/en/
Contact: Cleerly Media Contact
Christie Sheebert
press@cleerlyhealth.com
Keyword: North America, Colorado
Industry Keyword: Health Technology Health Technology Artificial Intelligence Psychology of Medical Devices
Source: Cleerly
Copyright Business Wire 2025.
Pub: 07/09/2025 09:00 am/disc: 07/09/2025 09:01 am
http://www.businesswire.com/news/home/20250709765120/en
Copyright Business Wire 2025.
